CVS Health (CVS) 10-K Summary — Year Ended Dec 31, 2025
CVS Health Corporation operates as a leading health solutions company with retail pharmacies, medical clinics, pharmacy benefits management, and health insurance. The filing reports higher revenue but lower profitability relative to revenue, and positive operating cash flow.
Key takeaway
Year ended Dec 31, 2025 · FY2025 10-K
CVS Health Corporation operates as a leading health solutions company with retail pharmacies, medical clinics, pharmacy benefits management, and health insurance. The filing reports higher revenue but lower profitability relative to revenue, and positive operating cash flow.
Financial snapshot
Selected annual figures reported with the filing, shown separately from the narrative summary.
Annual revenue
$402.1B
Revenue reported for the fiscal year.
Operating income
$4.7B
Income from operations reported for the year.
Net income
$1.8B
Net income reported for the year.
Operating cash flow
$10.6B
Cash generated by operating activities.
Annual revenue trend
Reported annual revenue and its change from the preceding fiscal year.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Dec 31, 2022 | $322.5B | +10.4% |
| Dec 31, 2023 | $357.8B | +10.9% |
| Dec 31, 2024 | $372.8B | +4.2% |
| Dec 31, 2025 | $402.1B | +7.8% |
Business overview
CVS Health provides health services through a large network of retail pharmacy locations, walk-in and primary care medical clinics, a pharmacy benefits manager serving millions of plan members, and health insurance products including Medicare Advantage and standalone Part D plans. The company aims to simplify healthcare and lower costs through an integrated, technology-driven model.
Financial performance
Revenue increased compared to the prior period, while operating income and net income were lower relative to revenue, indicating margin compression. Operating cash flow remained positive, supporting ongoing operations.
Material risks
The supplied filing context does not contain detailed risk factor descriptions; it only references the risk factors section in the table of contents. No specific material risks are elaborated in the provided excerpts.
Liquidity and capital
The filing references a discussion of liquidity and capital resources within the management discussion, but no specific themes or allocations are detailed in the supplied context.
What to watch
Monitor the company's revenue growth trajectory and profit margin trends in the next filing.